September 23 (SeeNews) - Bulgarian drug trader Sopharma Trading [BUL:SFT] decided to appoint its former board chairman, Ognyan Donev, as new chief executive officer (CEO) replacing Dimitar Dimitrov.
"The strategy of the Sopharma group in recent years is focused on strengthening the integration between the various businesses of the group so that even greater opportunities and synergies can be implemented," Sopharma Trading said in a bourse filing earlier this week.
Donev is also CEO and indirectly the biggest shareholder of Sopharma Trading's majority owner - drug maker Sopharma [BUL:SFA]. At the end of June, Sopharma held a 76.33% equity stake in Sopharma Trading, while Donev held directly a stake of under 5%.
As at 10:55 CET on Thursday, Sopharma Trading shares changed hands 1.0% higher at 5.05 levs on the Sofia bourse.
(1 euro = 1.95583 levs)